Skip to main content
Signal8

Erlander Mark

SEC insider (Form 3/4/5 filer). CIK 0001651537. Chief Executive Officer at Cardiff Oncology, Inc. (CRDF). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 11, 2025. Located in SAN DIEGO, CA.

Companies Erlander Mark has filed insider reports for

  • Cardiff Oncology, Inc. (CRDF): Director, Officer, Chief Executive Officer
Erlander Mark profile photo

Erlander Mark

CIK: 0001651537

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cardiff Oncology, Inc. logo
CRDF

Cardiff Oncology, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Cardiff Oncology, Inc. logo
    CRDF

    Cardiff Oncology, Inc.

    Mar 11, 2025
    Award

    Stock Options

    Direct
    758.4K shares-

1-1 of 1